The results showed that compared with a healthy population, CD44 and SLC7A11 mRNA levels were higher in CRC patients, but there was no difference in the expression levels of CD44 and SLC7A11 in different stages of CRC (Stage I to Stage IV) (Figure 3A). The gene discussed is CD44; the disease is colorectal carcinoma.